rs139775414

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_003060.4(SLC22A5):ā€‹c.1249A>Gā€‹(p.Met417Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000673 in 1,613,996 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.0034 ( 2 hom., cov: 33)
Exomes š‘“: 0.00039 ( 4 hom. )

Consequence

SLC22A5
NM_003060.4 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.928
Variant links:
Genes affected
SLC22A5 (HGNC:10969): (solute carrier family 22 member 5) Polyspecific organic cation transporters in the liver, kidney, intestine, and other organs are critical for elimination of many endogenous small organic cations as well as a wide array of drugs and environmental toxins. The encoded protein is a plasma integral membrane protein which functions both as an organic cation transporter and as a sodium-dependent high affinity carnitine transporter. The encoded protein is involved in the active cellular uptake of carnitine. Mutations in this gene are the cause of systemic primary carnitine deficiency (CDSP), an autosomal recessive disorder manifested early in life by hypoketotic hypoglycemia and acute metabolic decompensation, and later in life by skeletal myopathy or cardiomyopathy. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Apr 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0067510307).
BP6
Variant 5-132390886-A-G is Benign according to our data. Variant chr5-132390886-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 460395.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00338 (515/152244) while in subpopulation AFR AF= 0.0118 (488/41524). AF 95% confidence interval is 0.0109. There are 2 homozygotes in gnomad4. There are 242 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SLC22A5NM_003060.4 linkuse as main transcriptc.1249A>G p.Met417Val missense_variant 7/10 ENST00000245407.8 NP_003051.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SLC22A5ENST00000245407.8 linkuse as main transcriptc.1249A>G p.Met417Val missense_variant 7/101 NM_003060.4 ENSP00000245407 P1O76082-1

Frequencies

GnomAD3 genomes
AF:
0.00337
AC:
512
AN:
152126
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0117
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00111
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00335
GnomAD3 exomes
AF:
0.000994
AC:
250
AN:
251406
Hom.:
1
AF XY:
0.000640
AC XY:
87
AN XY:
135888
show subpopulations
Gnomad AFR exome
AF:
0.0124
Gnomad AMR exome
AF:
0.000896
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000132
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000391
AC:
571
AN:
1461752
Hom.:
4
Cov.:
30
AF XY:
0.000326
AC XY:
237
AN XY:
727174
show subpopulations
Gnomad4 AFR exome
AF:
0.0123
Gnomad4 AMR exome
AF:
0.000961
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000232
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000531
Gnomad4 OTH exome
AF:
0.000861
GnomAD4 genome
AF:
0.00338
AC:
515
AN:
152244
Hom.:
2
Cov.:
33
AF XY:
0.00325
AC XY:
242
AN XY:
74448
show subpopulations
Gnomad4 AFR
AF:
0.0118
Gnomad4 AMR
AF:
0.00111
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000441
Gnomad4 OTH
AF:
0.00332
Alfa
AF:
0.000609
Hom.:
1
Bravo
AF:
0.00413
ESP6500AA
AF:
0.0136
AC:
60
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00127
AC:
154
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.000237

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Renal carnitine transport defect Benign:3
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 15, 2021- -
Likely benign, criteria provided, single submitterin vitro;researchGiacomini Lab, University of California, San FranciscoOct 03, 2022- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenApr 01, 2023SLC22A5: BP4, BS1, BS2 -
Benign, criteria provided, single submitterclinical testingGeneDxAug 19, 2020This variant is associated with the following publications: (PMID: 24123366) -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMar 11, 2019Variant summary: SLC22A5 c.1249A>G (p.Met417Val) results in a conservative amino acid change located in the Major facilitator superfamily domain of the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0012 in 277134 control chromosomes, predominantly at a frequency of 0.012 within the African subpopulation in the gnomAD database, including 2 homozygotes. The observed variant frequency within African control individuals in the gnomAD database is approximately 3-folds higher than the estimated maximal expected allele frequency for a pathogenic variant in SLC22A5 causing Systemic Primary Carnitine Deficiency phenotype (0.0046), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African origin. To our knowledge, no occurrence of c.1249A>G in individuals affected with Systemic Primary Carnitine Deficiency and no experimental evidence demonstrating its impact on protein function have been reported. Two ClinVar submissions from clinical diagnostic laboratories (evaluation after 2014) cites the variant once as likely benign and once as benign. Based on the evidence outlined above, the variant was classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
13
DANN
Benign
0.83
DEOGEN2
Benign
0.13
T;.
Eigen
Benign
-0.88
Eigen_PC
Benign
-0.64
FATHMM_MKL
Benign
0.59
D
LIST_S2
Benign
0.34
T;T
MetaRNN
Benign
0.0068
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.76
N;.
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.38
T
PROVEAN
Benign
1.6
N;N
REVEL
Benign
0.069
Sift
Benign
0.39
T;T
Sift4G
Benign
0.53
T;T
Polyphen
0.0
B;.
Vest4
0.21
MVP
0.67
MPC
0.21
ClinPred
0.0011
T
GERP RS
1.9
Varity_R
0.047
gMVP
0.28

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs139775414; hg19: chr5-131726578; COSMIC: COSV99810247; COSMIC: COSV99810247; API